International Journal of Infectious Diseases

Article	Citations
Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts	584
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients	495
Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis	450
Role of favipiravir in the treatment of COVID-19	301
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa	300
Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis	290
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates	281
Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples	279
Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis	247
Factors affecting perceived effectiveness of COVID-19 prevention measures among Filipinos during Enhanced Community Quarantine in Luzon, Philippines: Integrating Protection Motivation Theory and exten	243
COVID-19 and healthcare workers: A systematic review and meta-analysis	237
Effectiveness of non-pharmaceutical interventions on COVID-19 transmission in 190 countries from 23 January to 13 April 2020	233
Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome	225
COVID-19: Poor outcomes in patients with zinc deficiency	209
Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers	208
Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients	205
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial	193
Nutritional status of patients with COVID-19	193
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa	186
The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB	184
Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study	181
An analysis of COVID-19 vaccine sentiments and opinions on Twitter	175
Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible	175
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review	168
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness	165

Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings	163
Healthcare worker infections and deaths due to COVID-19: A survey from 37 nations and a call for WHO to post national data on their website	157
Side effects and perceptions following Sinopharm COVID-19 vaccination	156
Mask use, risk-mitigation behaviours and pandemic fatigue during the COVID-19 pandemic in five cities in Australia, the UK and USA: A cross-sectional survey	146
Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention	143
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in gl	134
An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination	124
Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis	114
CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14	108
Possible aerosol transmission of COVID-19 associated with an outbreak in an apartment in Seoul, South Korea, 2020	107
Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis	105
Africa’s low COVID-19 mortality rate: A paradox?	100
Therapeutic plasma exchange in adults with severe COVID-19 infection	100
Mast cell activation symptoms are prevalent in Long-COVID	99
Asymptomatic hypoxia in COVID-19 is associated with poor outcome	97
Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review	96
SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021	94
Main differences between the first and second waves of COVID-19 in Madrid, Spain	94
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings	93
SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic	92
Treatment of SARS-CoV-2 with high dose oral zinc salts: A report on four patients	92
Mental health crisis under COVID-19 pandemic in Hong Kong, China	87
Infection sustained by lineage B.1.1.7 of SARS-CoV-2 is characterised by longer persistence and higher viral RNA loads in nasopharyngeal swabs	87
Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia	84
COVID-19 infection among healthcare workers in a national healthcare system: The Qatar experience	83
Clinical characteristics and outcomes of patients hospitalized with COVID-19 in Brazil: Results from the Brazilian COVID-19 registry	82
Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness	82
Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients	82
Characteristics of healthcare workers infected with COVID-19: A cross-sectional observational study	81
Marburg virus disease: A summary for clinicians	80
Antimalarial artemisinin-based combination therapies (ACT) and COVID-19 in Africa: In vitro inhibition of SARS-CoV-2 replication by mefloquine-artesunate	78
Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination	78
Clinical outcomes and characteristics of patients hospitalized for Influenza or COVID-19 in Germany	77
Cluster infections play important roles in the rapid evolution of COVID-19 transmission: A systematic review	76
Temporal and spatial analysis of COVID-19 transmission in China and its influencing factors	76
Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development	76
Oral manifestations in a patient with a history of asymptomatic COVID-19: Case report	73
Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples	72
The incubation period of COVID-19: A meta-analysis	72
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab	72
Antibody-dependent enhancement of coronavirus	71
EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count	71
Multisystem inflammatory syndrome in children (MIS-C): Report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic	71
Analysis of the predictive factors for a critical illness of COVID-19 during treatment － relationship between serum zinc level and critical illness of COVID-19 −	70
Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control	69
Increased outbreaks of monkeypox highlight gaps in actual disease burden in Sub-Saharan Africa and in animal reservoirs	69
Does gender influence clinical expression and disease outcomes in COVID-19? A systematic review and meta-analysis	69
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial	68
The role of IGRA in the diagnosis of tuberculosis infection, differentiating from active tuberculosis, and decision making for initiating treatment or preventive therapy of tuberculosis infection	68
Efficacy and safety of nintedanib for pulmonary fibrosis in severe pneumonia induced by COVID-19: An interventional study	66

Ending the epidemic of HIV/AIDS by 2030: Will there be an endgame to HIV, or an endemic HIV requiring an integrated health systems response in many countries?	65
Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2	65
The potential significance of high avidity immunoglobulin G (IgG) for protective immunity towards SARS-CoV-2	64
Critical illness myopathy after COVID-19	64
Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia	63
Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study	62
Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa	62
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient	62
SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens	62
Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients	61
Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection	60
Predictors and outcomes of healthcare-associated infections in COVID-19 patients	59
Anterior uveitis onset after bnt162b2 vaccination: is this just a coincidence?	59
Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar	59
Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic	58
Follow-up study on COVID-19 survivors one year after discharge from hospital	58
New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France	57
Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge	56
Respiratory syncytial virus and influenza epidemics disappearance in Korea during the 2020–2021 season of COVID-19	56
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study	56
Contact tracing with digital assistance in Taiwan’s COVID-19 outbreak response	56
Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients	56
Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals	55
Prognostic performance of troponin in COVID-19: A diagnostic meta-analysis and meta-regression	55
Sensitivity of different RT-qPCR solutions for SARS-CoV-2 detection	54
Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh	54
Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.	54
Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report	54
COVID-19 Vaccine Acceptance among Health Care Workers in the Kingdom of Saudi Arabia	54
Genomic sequencing effort for SARS-CoV-2 by country during the pandemic	54
Sudden sensorineural hearing loss after COVID-19 vaccination	53
Clinical features and risk factors associated with morbidity and mortality among patients with COVID-19 in northern Ethiopia	53
The Effect of Melatonin on Thrombosis, Sepsis and Mortality Rate in COVID-19 Patients	53
The high prevalence of asymptomatic SARS-CoV-2 infection reveals the silent spread of COVID-19	52
Human respiratory viruses, including SARS-CoV-2, circulating in the winter season 2019–2020 in Parma, Northern Italy	51
Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR	51
Saliva is a reliable and accessible source for the detection of SARS-CoV-2	51
Bacterial co-infection at hospital admission in patients with COVID-19	51
A meta-analysis of the incidence of venous thromboembolic events and impact of anticoagulation on mortality in patients with COVID-19	51
The role of children in household transmission of COVID-19: a systematic review and meta-analysis	51
The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States	50
Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge	50
COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report	50
The effect of ultraviolet C radiation against different N95 respirators inoculated with SARS-CoV-2	50
COX2 inhibition in the treatment of COVID-19: Review of literature to propose repositioning of celecoxib for randomized controlled studies	50
Was school closure effective in mitigating coronavirus disease 2019 (COVID-19)? Time series analysis using Bayesian inference	49
Clinical Characteristics of Asymptomatic Patients with COVID-19: A Nationwide Cohort Study in South Korea	49
Herpes zoster after COVID vaccination	49
SARS-CoV-2 clearance in COVID-19 patients with Novaferon treatment: A randomized, open-label, parallel-group trial	48
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study	48
Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database	48
Co-infection of SARS-CoV-2 with other respiratory viruses and performance of lower respiratory tract samples for the diagnosis of COVID-19	48
Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients	48
The impact of COVID-19 on health care–associated infections in intensive care units in low- and middle-income countries: International Nosocomial Infection Control Consortium (INICC) findings	47
Covid-19 and blood groups: ABO antibody levels may also matter	47
Arginine depletion as a therapeutic approach for patients with COVID-19	47
A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transfer	47
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity	47
Drug resistant TB – latest developments in epidemiology, diagnostics and management	47
Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis	47
SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, Northeast Brazil, February 2021	47
Metagenomic next-generation sequencing technology for detection of pathogens in blood of critically ill patients	47
Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia	46
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study	46
Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis	46
Presenting Symptoms and Predictors of Poor Outcomes Among 2,184 Patients with COVID-19 in Lagos State, Nigeria	46
Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa	45
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients	45
Air and surface contamination by SARS-CoV-2 virus in a tertiary hospital in Wuhan, China	45
Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study	44
COVID-19 vaccine acceptance in South Asia: a multi-country study	44
Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients	44
SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance	43
COVID-19 in people living with HIV: A multicenter case-series study	43
COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications	43
Impact of the COVID-19 pandemic on tuberculosis management in Spain	43
Relationship of the cycle threshold values of SARS-CoV-2 polymerase chain reaction and total severity score of computerized tomography in patients with COVID 19	43
The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects	42
Facemask use in community settings to prevent respiratory infection transmission: A rapid review and meta-analysis	42
Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period	42

Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection	42
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, Kenya	42
Immunological memory and neutralizing activity to a single dose of COVID-19 vaccine in previously infected individuals	42
The epidemiological and radiographical characteristics of asymptomatic infections with the novel coronavirus (COVID-19): A systematic review and meta-analysis	42
Pandemic preparedness and response to COVID-19 in South Asian countries	42
Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia	42
Association of schistosomiasis and HIV infections: A systematic review and meta-analysis	42
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay	41
First report on clinical and radiological features of COVID-19 pneumonitis in a Caucasian population: Factors predicting fibrotic evolution	41
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic	41
Trends in the disease burden of HBV and HCV infection in China from 1990-2019	41
Risk of COVID-19 morbidity and mortality among healthcare workers working in a Large Tertiary Care Hospital	41
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak	41
COVID toes: where do we stand with the current evidence?	41
Clinical applications of detecting IgG, IgM or IgA antibody for the diagnosis of COVID-19: A meta-analysis and systematic review	41
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening	41
Less severe course of COVID-19 is associated with elevated levels of antibodies against seasonal human coronaviruses OC43 and HKU1 (HCoV OC43, HCoV HKU1)	41
Characteristics of long-COVID among older adults: a cross-sectional study	41
Transmission dynamics of the COVID-19 epidemic in India and modeling optimal lockdown exit strategies	41
Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as of November 20, 2020	40
SARS-CoV-2: Viral Loads of Exhaled Breath and Oronasopharyngeal Specimens in Hospitalized Patients with COVID-19	40
Symptoms Experienced at the Acute Phase of SARS-CoV-2 Infection as Risk Factor of Long-term Post-COVID Symptoms: The LONG-COVID-EXP-CM Multicenter Study	40
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa	39
The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients	39
Zoonotic Tuberculosis – The Changing Landscape	39
Emergence and outcomes of the SARS-CoV-2 ‘Marseille-4’ variant	39
Persistent replication of SARS-CoV-2 in a severely immunocompromised patient treated with several courses of remdesivir	39
HIV/SARS-CoV-2 co-infection: T cell profile, cytokine dynamics and role of exhausted lymphocytes	38
Appropriate use of tocilizumab in COVID-19 infection	38
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study	38
Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young migrant workers with reduced risk of severe disease	38
Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States	38
Performance of the quick COVID-19 severity index and the Brescia-COVID respiratory severity scale in hospitalized patients with COVID-19 in a community hospital setting	38
Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome	38
Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters	38
Prolonged and severe SARS-CoV-2 infection in patients under B-cell-depleting drug successfully treated: A tailored approach	38
Antimicrobial resistance: A challenge awaiting the post-COVID-19 era	37
Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis	37
Transmission onset distribution of COVID-19	37
Active prescription of low-dose aspirin during or prior to hospitalization and mortality in COVID-19: A systematic review and meta-analysis of adjusted effect estimates	37
Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation	37
Spread of COVID-19 and policy responses in Vietnam: An overview	37
Evolution and genetic diversity of SARS-CoV-2 in Africa using whole genome sequences	37
Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial	36
Lockdown and unlock for the COVID-19 pandemic and associated residential mobility in India	36
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis	36
Prevalence of Parental refusal rate and its associated factors in routine immunization by using WHO Vaccine Hesitancy tool: A Cross sectional study at district Bannu, KP, Pakistan	36
Minimizing the impact of the triple burden of COVID-19, tuberculosis and HIV on health services in sub-Saharan Africa	36
COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study	36
A genetic barcode of SARS-CoV-2 for monitoring global distribution of different clades during the COVID-19 pandemic	36
A simple approach to optimum pool size for pooled SARS-CoV-2 testing	36
Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China	36
Third wave of COVID-19 in Madrid, Spain	36
Antibiotic use in Kenyan public hospitals: Prevalence, appropriateness and link to guideline availability	36
COVID-19 hospital outbreaks: Protecting healthcare workers to protect frail patients. An Italian observational cohort study	36
SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections	36
Value of routine whole genome sequencing for Mycobacterium tuberculosis drug resistance detection	36
Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns	35
Circulating activated neutrophils in COVID-19: An independent predictor for mechanical ventilation and death	35
Infectivity versus fatality of SARS-CoV-2 mutations and influenza	35
Tracking COVID-19 with wastewater to understand asymptomatic transmission	35
A shorter symptom onset to remdesivir treatment (SORT) interval is associated with a lower mortality in moderate-to-severe COVID-19: A real-world analysis	35
Efficacy of ribavirin and interferon-α therapy for hospitalized patients with COVID-19: A multicenter, retrospective cohort study	35
What factors drive the satisfaction of citizens with governments’ responses to COVID-19?	35
Tricuspid annular plane systolic excursion (TAPSE) measured by echocardiography and mortality in COVID-19: A systematic review and meta-analysis	35
The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review	35
A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants	35
Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use	35
A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19	35
Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms	34
The impact of universal face masking and enhanced hand hygiene for COVID-19 disease prevention on the incidence of hospital-acquired infections in a Taiwanese hospital	34
Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19	34
The assessment of transmission efficiency and latent infection period in asymptomatic carriers of SARS-CoV-2 infection	34
Is Colombia an example of successful containment of the 2020 COVID-19 pandemic? A critical analysis of the epidemiological data, March to July 2020	34
Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic	34
Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China	34
Performance of the T-SPOTⓇ.COVID test for detecting SARS-CoV-2-responsive T cells	33
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness	33
Patterns of viral clearance in the natural course of asymptomatic COVID-19: Comparison with symptomatic non-severe COVID-19	33
Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people	33
Global influenza vaccination rates and factors associated with influenza vaccination	33
Detecting the presence of bacteria in low-volume preoperative aspirated synovial fluid by metagenomic next-generation sequencing	33
Descriptive epidemiology of rickettsial infections in Japan: Scrub typhus and Japanese spotted fever, 2007–2016	33
Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort study	33
The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010–20	32
Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges	32
Serological cross-reactivity using a SARS-CoV-2 ELISA test in acute Zika virus infection, Colombia	32
Morbidity and mortality of respiratory syncytial virus infection in hospitalized adults: Comparison with seasonal influenza	32
Serum Calcium and Vitamin D levels: Correlation with severity of COVID-19 in hospitalized patients in Royal Hospital, Oman	32
Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: Systematic review and meta-analys	32
Epidemiology and costs of dengue in Brazil: a systematic literature review	32
Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients	32
SARS-CoV-2 seroprevalence and associated factors in Manaus, Brazil: baseline results from the DETECTCoV-19 cohort study	32
The efficacy and adverse effects of favipiravir on patients with COVID-19: A systematic review and meta-analysis of published clinical trials and observational studies	32
Rapid visual detection of hepatitis C virus using a reverse transcription loop-mediated isothermal amplification assay	31